Complexity of danger: The diverse nature of damage-associated molecular patterns

Journal of Biological Chemistry

Volumn 289, Issue 51, 2014, Pages 35237-35245

  Schaefer, Liliana ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

EXTRACELLULAR SPACE; IMMUNE RECEPTORS; INFLAMMATORY RESPONSE; MOLECULAR PATTERNS; PATTERN RECOGNITION RECEPTORS; SIGNALING PATHWAYS; STRUCTURAL CHARACTERISTICS;

PATTERN RECOGNITION;

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN A; CALGRANULIN B; CRYOPYRIN; DNA; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; PATTERN RECOGNITION RECEPTOR; PROTEOGLYCAN; TOLL LIKE RECEPTOR;

AUTOPHAGY; CELL DEATH; CELL NUCLEUS; CYTOKINE RELEASE; CYTOSOL; DAMAGE ASSOCIATED MOLECULAR PATTERN; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MITOCHONDRION; MOLECULE; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; METABOLISM;

ANIMALS; CYTOSOL; EXTRACELLULAR MATRIX; HUMANS; INFLAMMASOMES; INFLAMMATION; MODELS, IMMUNOLOGICAL; PROTEOGLYCANS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

EID: 84919346965     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R114.619304     Document Type: Review

References (100)

1. Mogensen, T. H. (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22, 240-273
2. Piccinini, A. M., and Midwood, K. S. (2010) DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 672395
3. Broggi, A., and Granucci, F. (2014) Microbe- and danger-induced inflammation. Mol. Immunol. 63, 127-133
4. Rosin, D. L., and Okusa, M. D. (2011) Dangers within: DAMP responses to damage and cell death in kidney disease. J. Am. Soc. Nephrol. 22, 416-425
5. Moreth, K., Iozzo, R. V., and Schaefer, L. (2012) Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle 11, 2084-2091
6. Chen, G. Y., and Nunez, G. (2010) Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837
7. Frey, H., Schroeder, N., Manon-Jensen, T., Iozzo, R. V., and Schaefer, L. (2013) Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J. 280, 2165-2179
8. Chun, K. H., and Seong, S. Y. (2010) CD14 but not MD2 transmit signals from DAMP. Int. Immunopharmacol. 10, 98-106
9. Escamilla-Tilch, M., Filio-Rodríguez, G., García-Rocha, R., Mancilla-Herrera, I., Mitchison, N. A., Ruiz-Pacheco, J. A., Sánchez-García, F. J., Sandoval-Borrego, D., and Vázquez-Sánchez, E. A. (2013) The interplay between pathogen-associated and danger-associated molecular patterns: an inflammatory code in cancer? Immunol. Cell Biol. 91, 601-610
10. O'Neill, L. A., and Bowie, A. G. (2007) The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353-364
11. Anders, H. J., and Schaefer, L. (2014) Beyond tissue injury: damage-associated molecular patterns, Toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J. Am. Soc. Nephrol. 25, 1387-1400
12. Maeda, A., and Fadeel, B. (2014) Mitochondria released by cells undergoing TNF-α-induced necroptosis act as danger signals. Cell Death Dis. 5, e1312
13. Hsieh, L. T., Nastase, M. V., Zeng-Brouwers, J., Iozzo, R. V., and Schaefer, L. (2014) Soluble biglycan as a biomarker of inflammatory renal diseases. Int. J. Biochem. Cell Biol. 54, 223-235
14. Merline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralha?o, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., and Schaefer, L. (2011) Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and mi-croRNA-21. Sci. Signal. 4, ra75
15. Moreth, K., Brodbeck, R., Babelova, A., Gretz, N., Spieker, T., Zeng-Brouwers, J., Pfeilschifter, J., Young, M. F., Schaefer, R. M., and Schaefer, L. (2010) The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J. Clin. Invest. 120, 4251-4272
16. Schaefer, L., Babelova, A., Kiss, E., Hausser, H. J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Go?tte, M., Malle, E., Schaefer, R. M., and Gro?ne, H. J. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115, 2223-2233
17. Nastase, M. V., Young, M. F., and Schaefer, L. (2012) Biglycan: a multivalent proteoglycan providing structure and signals. J. Histochem. Cytochem. 60, 963-975
18. Babelova, A., Moreth, K., Tsalastra-Greul, W., Zeng-Brouwers, J., Eickelberg, O., Young, M. F., Bruckner, P., Pfeilschifter, J., Schaefer, R. M., Gro?ne, H. J., and Schaefer, L. (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X receptors. J. Biol. Chem. 284, 24035-24048
19. Wu, F., Vij, N., Roberts, L., Lopez-Briones, S., Joyce, S., and Chakravarti, S. (2007) A novel role of the lumican core protein in bacterial lipo-polysaccharide-induced innate immune response. J. Biol. Chem. 282, 26409-26417
20. Schaefer, L., and Iozzo, R. V. (2012) Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. Curr. Opin. Genet. Dev. 22, 56-57
21. Nastase, M. V., Iozzo, R. V., and Schaefer, L. (2014) Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology. Biochim. Biophys. Acta 1840, 2460-2470
22. Kim, S., Takahashi, H., Lin, W. W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J. L., and Karin, M. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106
23. Jiang, D., Liang, J., and Noble, P. W. (2007) Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23, 435-461
24. Singleton, P. A. (2014) Hyaluronan regulation of endothelial barrier function in cancer. Adv. Cancer Res. 123, 191-209
25. Goldberg, R., Meirovitz, A., Hirshoren, N., Bulvik, R., Binder, A., Rubinstein, A. M., and Elkin, M. (2013) Versatile role of heparanase in inflammation. Matrix Biol. 32, 234-240
26. Patel, V. N., Knox, S. M., Likar, K. M., Lathrop, C. A., Hossain, R., Eftekhari, S., Whitelock, J. M., Elkin, M., Vlodavsky, I., and Hoffman, M. P. (2007) Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development 134, 4177-4186
27. Barbouri, D., Afratis, N., Gialeli, C., Vynios, D. H., Theocharis, A. D., and Karamanos, N. K. (2014) Syndecans as modulators and potential pharmacological targets in cancer progression. Front. Oncol. 4, 4
28. Mani, K., Cheng, F., and Fransson, L. A. (2006) Defective nitric oxide-dependent, deaminative cleavage of glypican-1 heparan sulfate in Ni-emann-Pick C1 fibroblasts. Glycobiology 16, 711-718
29. Brennan, T. V., Lin, L., Huang, X., Cardona, D. M., Li, Z., Dredge, K., Chao, N. J., and Yang, Y. (2012) Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. Blood 120, 2899-2908
30. Goodall, K. J., Poon, I. K., Phipps, S., and Hulett, M. D. (2014) Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4. PLoS One 9, e109596
31. Zhang, X., Chen, C. T., Bhargava, M., and Torzilli, P. A. (2012) A comparative study of fibronectin cleavage by MMP-1, -3, -13, and -14. Cartilage 3, 267-277
32. Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., and Strauss, J. F., 3rd. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233
33. Smiley, S. T., King, J. A., and Hancock, W. W. (2001) Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167, 2887-2894
34. Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., Brennan, F., and Foxwell, B. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15, 774-780
35. Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., and Hauser, C. J. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107
36. Krysko, D. V., Agostinis, P., Krysko, O., Garg, A. D., Bachert, C., Lambrecht, B. N., and Vandenabeele, P. (2011) Emerging role of damageassociated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 32, 157-164
37. Wenceslau, C. F., McCarthy, C. G., Szasz, T., Spitler, K., Goulopoulou, S., Webb, R. C., and Working Group on DAMPs in Cardiovascular Disease (2014) Mitochondrial damage-associated molecular patterns and vascular function. Eur. Heart J. 35, 1172-1177
38. Ferna?ndez-Ruiz, I., Arnalich, F., Cubillos-Zapata, C., Herna?ndez-Jimé-nez, E., Moreno-Gonza?lez, R., Toledano, V., Ferna?ndez-Velasco, M., Vallejo-Cremades, M. T., Esteban-Burgos, L., de Diego, R. P., Llamas-Matias, M. A., García-Arumi, E., Martí, R., Bosca?, L., Andreu, A. L., Lo?pez-Sendo?n, J. L., and Lo?pez-Collazo, E. (2014) Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarction. PLoS One 9, e95073
39. Lee, Y. L., King, M. B., Gonzalez, R. P., Brevard, S. B., Frotan, M. A., Gillespie, M. N., and Simmons, J. D. (2014) Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury. J. Surg. Res. 191, 286-289
40. Little, J. P., Simtchouk, S., Schindler, S. M., Villanueva, E. B., Gill, N. E., Walker, D. G., Wolthers, K. R., and Klegeris, A. (2014) Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia. Mol. Cell. Neurosci. 60, 88-96
41. Zhang, Q., Kang, R., Zeh, H. J., 3rd, Lotze, M. T., and Tang, D. (2013) DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death. Autophagy 9, 451-458
42. Hou, W., Zhang, Q., Yan, Z., Chen, R., Zeh Iii, H. J., Kang, R., Lotze, M. T., and Tang, D. (2013) Strange attractors: DAMPs and autophagy link tumor cell death and immunity. Cell Death Dis. 4, e966
43. Thorburn, J., Horita, H., Redzic, J., Hansen, K., Frankel, A. E., and Thorburn, A. (2009) Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ. 16, 175-183
44. Li, W., Zhu, S., Li, J., Assa, A., Jundoria, A., Xu, J., Fan, S., Eissa, N. T., Tracey, K. J., Sama, A. E., and Wang, H. (2011) EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem. Pharmacol. 81, 1152-1163
45. Ayna, G., Krysko, D. V., Kaczmarek, A., Petrovski, G., Vandenabeele, P., and Fésu?s, L. (2012) ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS One 7, e40069
46. Fader, C. M., Aguilera, M. O., and Colombo, M. I. (2012) ATP is released from autophagic vesicles to the extracellular space in a VAMP7-dependent manner. Autophagy 8, 1741-1756
47. Shi, C. S., Shenderov, K., Huang, N. N., Kabat, J., Abu-Asab, M., Fitzgerald, K. A., Sher, A., and Kehrl, J. H. (2012) Activation of autophagy by inflammatory signals limits IL-1- production by targeting ubiquitinated inflammasomes for destruction. Nat. Immunol. 13, 255-263
48. Nakahira, K., Haspel, J. A., Rathinam, V. A., Lee, S. J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., Fitzgerald, K. A., Ryter, S. W., and Choi, A. M. (2011) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222-230
49. Dupont, N., Jiang, S., Pilli, M., Ornatowski, W., Bhattacharya, D., and Deretic, V. (2011) Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1-. EMBO J. 30, 4701-4711
50. Pisetsky, D. S. (2014) The translocation of nuclear molecules during inflammation and cell death. Antioxid. Redox Signal. 20, 1117-1125
51. Mu?ller, S., Scaffidi, P., Degryse, B., Bonaldi, T., Ronfani, L., Agresti, A., Beltrame, M., and Bianchi, M. E. (2001) New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 20, 4337-4340
52. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K. R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P. E., Abumrad, N. N., Sama, A., and Tracey, K. J. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251
53. Rovere-Querini, P., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, I. E., Mu?ller, S., Iannacone, M., Traversari, C., Bianchi, M. E., and Manfredi, A. A. (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5, 825-830
54. Scaffidi, P., Misteli, T., and Bianchi, M. E. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195
55. Beyer, C., Stearns, N. A., Giessl, A., Distler, J. H., Schett, G., and Pisetsky, D. S. (2012) The extracellular release ofDNAand HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun. 18, 727-737
56. Spencer, D. M., Mobarrez, F., Wallén, H., and Pisetsky, D. S. (2014) The expression of HMGB1 on microparticles from Jurkat and HL-60 cells undergoing apoptosis in vitro. Scand. J. Immunol. 80, 101-110
57. Yang, H., Lundba?ck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., and Antoine, D. J. (2012) Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 18, 250-259
58. Allam, R., Scherbaum, C. R., Darisipudi, M. N., Mulay, S. R., Ha?gele, H., Lichtnekert, J., Hagemann, J. H., Rupanagudi, K. V., Ryu, M., Schwarzenberger, C., Hohenstein, B., Hugo, C., Uhl, B., Reichel, C. A., Krombach, F., Monestier, M., Liapis, H., Moreth, K., Schaefer, L., and Anders, H. J. (2012) Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J. Am. Soc. Nephrol. 23, 1375-1388
59. Xu, J., Zhang, X., Pelayo, R., Monestier, M., Ammollo, C. T., Semeraro, F., Taylor, F. B., Esmon, N. L., Lupu, F., and Esmon, C. T. (2009) Extracellular histones are major mediators of death in sepsis. Nat. Med. 15, 1318-1321
60. Papayannopoulos, V., and Zychlinsky, A. (2009) NETs: a new strategy for using old weapons. Trends Immunol. 30, 513-521
61. Tran, T. T., Groben, P., and Pisetsky, D. S. (2008) The release ofDNAinto the plasma of mice following hepatic cell death by apoptosis and necrosis. Biomarkers 13, 184-200
62. Jiang, N., Reich, C. F., 3rd, and Pisetsky, D. S. (2003) Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells. Blood 102, 2243-2250
63. Kono, H., Chen, C. J., Ontiveros, F., and Rock, K. L. (2010) Uric acid promotes an acute inflammatory response to sterile cell death in mice. J. Clin. Invest. 120, 1939-1949
64. Eisenbacher, J. L., Schrezenmeier, H., Jahrsdo?rfer, B., Kaltenmeier, C., Rojewski, M. T., Yildiz, T., Beyer, T., Erle, A., Wiegmann, D. S., Grassl, S., Hang, R., Ko?rper, S., Wiesneth, M., Lotze, M. T., and Lotfi, R. (2014) S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10-/IDO- lymphocytes. J. Immunol. 192, 6102-6110
65. Shi, Y., Evans, J. E., and Rock, K. L. (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516-521
66. Johnson, R. J., Titte, S., Cade, J. R., Rideout, B. A., and Oliver, W. J. (2005) Uric acid, evolution and primitive cultures. Semin. Nephrol. 25, 3-8
67. Foell, D., Wittkowski, H., Vogl, T., and Roth, J. (2007) S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28-37
68. Rammes, A., Roth, J., Goebeler, M., Klempt, M., Hartmann, M., and Sorg, C. (1997) Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 272, 9496-9502
69. Tsai, S. Y., Segovia, J. A., Chang, T. H., Morris, I. R., Berton, M. T., Tessier, P. A., Tardif, M. R., Cesaro, A., and Bose, S. (2014) DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog. 10, e1003848
70. Bianchi, M. E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5
71. Vabulas, R. M., Wagner, H., and Schild, H. (2002) Heat shock proteins as ligands of Toll-like receptors. Curr. Top. Microbiol. Immunol. 270, 169-184
72. Lehnardt, S., Schott, E., Trimbuch, T., Laubisch, D., Krueger, C., Wulczyn, G., Nitsch, R., and Weber, J. R. (2008) A vicious cycle involving release of heat shock protein 60 from injured cells and activation of Toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 28, 2320-2331
73. Clayton, A., Turkes, A., Navabi, H., Mason, M. D., and Tabi, Z. (2005) Induction of heat shock proteins in B-cell exosomes. J. Cell Sci. 118, 3631-3638
74. Botos, I., Segal, D. M., and Davies, D. R. (2011) The structural biology of Toll-like receptors. Structure 19, 447-459
75. Casanova, J. L., Abel, L., and Quintana-Murci, L. (2011) Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29, 447-491
76. Oldenburg, M., Kru?ger, A., Ferstl, R., Kaufmann, A., Nees, G., Sigmund, A., Bathke, B., Lauterbach, H., Suter, M., Dreher, S., Koedel, U., Akira, S., Kawai, T., Buer, J., Wagner, H., Bauer, S., Hochrein, H., and Kirschning, C. J. (2012) TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337, 1111-1115
77. Kawai, T., and Akira, S. (2007) Signaling to NF--B by Toll-like receptors. Trends Mol. Med. 13, 460-469
78. Ivanov, S., Dragoi, A. M., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, G., Yap, G. S., Wan, Y., Biron, C. A., Bianchi, M. E., Wang, H., and Chu, W. M. (2007) A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110, 1970-1981
79. Liu-Bryan, R., Scott, P., Sydlaske, A., Rose, D. M., and Terkeltaub, R. (2005) Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 52, 2936-2946
80. Sorci, G., Giovannini, G., Riuzzi, F., Bonifazi, P., Zelante, T., Zagarella, S., Bistoni, F., Donato, R., and Romani, L. (2011) The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation. PLoS Pathog. 7, e1001315
81. Taylor, K. R., Yamasaki, K., Radek, K. A., Di Nardo, A., Goodarzi, H., Golenbock, D., Beutler, B., and Gallo, R. L. (2007) Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 282, 18265-18275
82. Hodgkinson, C. P., Patel, K., and Ye, S. (2008) Functional Toll-like receptor 4 mutations modulate the response to fibrinogen. Thromb. Haemost. 100, 301-307
83. Moreth, K., Frey, H., Hubo, M., Zeng-Brouwers, J., Nastase, M. V., Hsieh, L. T., Haceni, R., Pfeilschifter, J., Iozzo, R. V., and Schaefer, L. (2014) Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol. 35, 143-151
84. Lee, E. J., and Park, J. H. (2013) Receptor for Advanced glycation endproducts (RAGE), its ligands, and soluble RAGE: potential biomarkers for diagnosis and therapeutic targets for human renal diseases. Genomics Inform. 11, 224-229
85. Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W., Clauss, M., et al. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987-14997
86. Rani, S. G., Sepuru, K. M., and Yu, C. (2014) Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE). Biochim. Biophys. Acta 1844, 1718-1728
87. Chaney, M. O., Stine, W. B., Kokjohn, T. A., Kuo, Y. M., Esh, C., Rahman, A., Luehrs, D. C., Schmidt, A. M., Stern, D., Yan, S. D., and Roher, A. E. (2005) RAGE and amyloid - interactions: atomic force microscopy and molecular modeling. Biochim. Biophys. Acta 1741, 199-205
88. Ramasamy, R., Yan, S. F., and Schmidt, A. M. (2011) Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann. N.Y. Acad. Sci. 1243, 88-102
89. Xie, J., Méndez, J. D., Méndez-Valenzuela, V., and Aguilar-Herna?ndez, M. M. (2013) Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell. Signal. 25, 2185-2197
90. Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., and Tschopp, J. (2004) NALP3 forms an IL-1--processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325
91. Gasse, P., Riteau, N., Charron, S., Girre, S., Fick, L., Pétrilli, V., Tschopp, J., Lagente, V., Quesniaux, V. F., Ryffel, B., and Couillin, I. (2009) Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 179, 903-913
92. Hoffman, H. M., Scott, P., Mueller, J. L., Misaghi, A., Stevens, S., Yancopoulos, G. D., Murphy, A., Valenzuela, D. M., and Liu-Bryan, R. (2010) Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice. Arthritis Rheum. 62, 2170-2179
93. Yamasaki, K., Muto, J., Taylor, K. R., Cogen, A. L., Audish, D., Bertin, J., Grant, E. P., Coyle, A. J., Misaghi, A., Hoffman, H. M., and Gallo, R. L. (2009) NLRP3/cryopyrin is necessary for interleukin-1- (IL-1-) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J. Biol. Chem. 284, 12762-12771
94. Allam, R., Darisipudi, M. N., Tschopp, J., and Anders, H. J. (2013) Histones trigger sterile inflammation by activating the NLRP3 inflammasome. Eur. J. Immunol. 43, 3336-3342
95. Netea, M. G., Simon, A., van de Veerdonk, F., Kullberg, B. J., Van der Meer, J. W., and Joosten, L. A. (2010) IL-1- processing in host defense: beyond the inflammasomes. PLoS Pathog. 6, e1000661
96. Urbonaviciute, V., and Voll, R. E. (2011) High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus. J. Intern. Med. 270, 309-318
97. Wheeler, D. S., Chase, M. A., Senft, A. P., Poynter, S. E., Wong, H. R., and Page, K. (2009) Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respir. Res. 10, 31
98. Li, X., Fang, P., Mai, J., Choi, E. T., Wang, H., and Yang, X. F. (2013) Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J. Hematol. Oncol. 6, 19
99. Qiu, J., Nishimura, M., Wang, Y., Sims, J. R., Qiu, S., Savitz, S. I., Salomone, S., and Moskowitz, M. A. (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 28, 927-938
100. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J. L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., Mé-tivier, D., Larochette, N., van Endert, P., Ciccosanti, F., Piacentini, M., Zitvogel, L., and Kroemer, G. (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54-61